| What if new drug delivery methods revolutionised medicine? |
|---|
| Nanoparticles lie at the heart of a new method for delivering medicines inside the body – and they were crucial to the success of the Covid-19 mRNA vaccines. This new drug delivery method and others could transform the way we treat disease, potentially boosting the treatment of Alzheimer's, Parkinson's and HIV, among others. Insulin and Covid-19 vaccines might even become available as pills. Can the European Union stay on top of this trend? And what challenges lie ahead? |
Nanoparticles lie at the heart of a new method for delivering medicines inside the body – and they were crucial to the success of the Covid-19 mRNA vaccines. This new drug delivery method and others could transform the way we treat disease, potentially boosting the treatment of Alzheimer's, Parkinson's and HIV, among others. Insulin and Covid-19 vaccines might even become available as pills. Can the European Union stay on top of this trend? And what challenges lie ahead?
|
- Publication type:
- policy brief
- Publication language:
- English
- Publication date:
- 2021-10
- Publication URL:
- https://www.europarl.europa.eu/RegData/etudes/ATAG/2021/697183/EPRS_ATA(2021)697183_EN.pdf
- Institute:
- European Parliament / Panel for the Future of Science and Technology (STOA) (STOA)
- Country:
- EU
